Bowman & CO S.C. Dexcom Inc Transaction History
Bowman & CO S.C.
- $170 Million
- Q2 2024
A detailed history of Bowman & CO S.C. transactions in Dexcom Inc stock. As of the latest transaction made, Bowman & CO S.C. holds 5,924 shares of DXCM stock, worth $412,902. This represents 0.4% of its overall portfolio holdings.
Number of Shares
5,924
Previous 5,397
9.76%
Holding current value
$412,902
Previous $748,000
10.29%
% of portfolio
0.4%
Previous 0.46%
Shares
2 transactions
Others Institutions Holding DXCM
# of Institutions
1,058Shares Held
361MCall Options Held
4.11MPut Options Held
3.63M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.24 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.41 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.14 Billion0.08% of portfolio
-
Baillie Gifford & CO15MShares$1.05 Billion0.77% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$833 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $26.9B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...